Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins.
52W Range
9thpctl
Volume
0.41×avg
Market Cap
75.50MUSD
P/E Ratio
-3.5TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Gain Therapeutics, Inc.
GANXNASDAQ Global Market·USD·Closed
Gain Therapeutics, Inc.
GANXNASDAQ·USD·Closed
$1.77
−4.32%
$1.77
−$0.08 (4.32%)
52W Range
9thpctl
Volume
0.41×avg
Mkt Cap
75.50MUSD
P/E
-3.5TTM
Div Yield
–ann
GANX: Gain Therapeutics, Inc. Stock Analysis | finqOS
